Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **alpha-globin gene** refers principally to two nearly identical genes, **HBA1** and **HBA2**, located at the alpha-globin locus on chromosome 16. They encode the **alpha-globin protein**, a critical subunit of hemoglobin. Hemoglobin is the main oxygen-carrying protein in red blood cells, composed of two alpha and two beta subunits[3][4][7][8]. Alpha-globin gene expression is tightly regulated during development and is essential for normal oxygen transport and erythrocyte function. Loss or mutation of these genes leads to a range of **alpha thalassemia syndromes** and other hemoglobinopathies, from silent carrier status to severe, life-threatening anemia[3][5][7]. The gene itself is not a classical pharmacological target (e.g., it is not a receptor or enzyme) but is pivotal in molecular diagnostics and gene therapy research for blood disorders[3][5].
Not a direct pharmacological target. Some therapies (e.g., gene editing, hydroxyurea) modulate *globin gene expression* or compensate for its loss but do not bind or inhibit the gene/protein directly[3][5].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-globin gene (HBA).